Jul 20, 2026 02:52AM
May 14, 2026 06:08AM
May 11, 2026 05:04PM
Apr 9, 2026 05:07PM
Mar 17, 2026 05:03PM
Jan 12, 2026 07:06AM
Nov 10, 2025 07:00AM AN2 Therapeutics partners with GSK on tuberculosis drug development
Aug 12, 2025 05:15PM
Aug 12, 2025 07:02AM
Jul 23, 2025 07:00AM
Jun 30, 2025 07:02AM
May 13, 2025 04:01PM
May 5, 2025 04:05AM
May 1, 2025 04:00PM AN2 Therapeutics, Inc (ANTX) Reports Data from the Phase 3 Portion of Previously Terminated EBO-301 Study
Mar 26, 2025 04:06AM
Mar 26, 2025 01:46AM
Mar 25, 2025 04:43PM
Feb 25, 2025 04:08AM
Feb 24, 2025 07:03AM
Feb 20, 2025 04:07AM
Feb 3, 2025 04:13AM JMP Securities Reiterates Market Outperform Rating on AN2 Therapeutics (ANTX)
Jan 28, 2025 05:42AM
Nov 18, 2024 02:43AM
Oct 17, 2024 07:03AM
Aug 16, 2024 07:02AM
Aug 13, 2024 04:12PM
Aug 9, 2024 08:37AM
Aug 8, 2024 04:30PM AN2 Therapeutics, Inc (ANTX) Provides Update on EBO-301 Phase 2/3 Study of Epetraborole

423,243 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All